Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin in active lupus nephritis
NCT02949973Phase 2Completed
- Sponsor
- Aurinia
- Start
- Jun 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of voclosporin in lupus nephritis (LN), sponsored by Aurinia. Primary endpoints: Number of Participants With Reduction or Normalization of Urine Protein/Creatinine Ratio at 24 weeks, Number of Participants With Reduction or Normalization of Anti-dsDNA at 24 weeks and 2 more. Started Jun 2015; status: completed.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT02949973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02949973.